The exercise ECG is an integral part within the evaluation algorithm for diagnosis and risk stratification of patients with stable ischaemic heart disease (SIHD). There is evidence, both older and new, that the exercise ECG can be an effective and cost-efficient option for patients capable of performing at maximal levels of exercise with suitable resting ECG findings. In this review, we will highlight the major dilemmas in interpreting suspected coronary artery disease symptoms in women and identify optimal strategies for employing exercise ECG as a first-line diagnostic test in the SIHD evaluation algorithm. We will highlight current evidence as well as recent guideline statements on this subject. Trial registration number NCT01471522; Pre-results.In today's practice of cardiovascular medicine, diverse technology is available to aid diagnosis and risk stratification of patients with stable ischaemic heart disease (SIHD) that include those with suspected and known obstructive coronary artery disease (CAD). These patients represent the core of eligible patients who may be referred for a diagnostic evaluation using exercise ECG or a CAD noninvasive imaging modality.1 Although for many physicians there is a perception that all patients require some form of imaging to diagnose CAD, there is evidence, both old and new, that the exercise ECG can be effective and cost-efficient for patients capable of performing at maximal levels of exercise with suitable resting ECG findings.
2Our focus on the diagnostic evaluation of women with SIHD is important as there are common misperceptions that the exercise ECG is inaccurate in women and that alternative approaches should be employed to a greater extent, including non-invasive imaging and invasive coronary angiography. Important considerations for the exercise ECG are the abundant evidence on prognostication and diagnostic accuracy in women and its comparative effectiveness compared with other modalities such as nuclear imaging.2 In this review, we will highlight the major dilemmas in interpreting suspected CAD symptoms in women and identify optimal strategies for employing exercise ECG as a first-line diagnostic test in the SIHD evaluation algorithm. We will highlight current evidence as well as a recent expert consensus statement from the American Heart Association (AHA) on this subject.3